Skip to content
Moojaz — موجز
Search
Menu
HomeRegionsMaghrebAfricaMiddle EastEuropeAsiaAmericasWorldSectionsPoliticsEconomySecurityHealthScienceTechnologyAIEnvironmentCultureSportsSearch
Morocco
File

Morocco: Nivestim batch recall

This dossier follows the Moroccan medicines agency’s alert concerning Nivestim batch NG0631 and documented follow-up to the recall.

Last updated : 1 key moments
Generic 10 ml syringe.
Generic syringe, 2004; not Nivestim or the recalled batch. Erich Schulz / Wikimedia Commons, public domain. — Erich Schulz / Wikimedia Commons — domaine public, photographie de 2004 ; contraste modifié dans la version Commons.

Where things stand

As of 30 October 2026, AMMPS has announced a precautionary recall of batch NG0631. Other batches are not affected.

Reported information

Nivestim: AMMPS announces precautionary recall of batch NG0631

Morocco’s medicines agency AMMPS announced on 30 October 2026 a precautionary recall of Nivestim 30 MU/0.5 ml batch NG0631, supplied in packs of five prefilled syringes, in agreement with Pfizer.

Generic 10 ml syringe.
Generic syringe, 2004; not Nivestim or the recalled batch. Erich Schulz / Wikimedia Commons, public domain. — Erich Schulz / Wikimedia Commons — domaine public, photographie de 2004 ; contraste modifié dans la version Commons.

The alert cites an incident affecting a cold room’s temperature recording system. Professionals are instructed to stop distributing, dispensing and using this batch, quarantine remaining stock and arrange returns with Pfizer.

Other batches are not affected. The published reason concerns temperature recording; it does not establish that the medicine itself experienced a temperature excursion. The notice also gives no duration for the incident or results from any product testing.

Sources 3